This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Oct 1;124(19):3797.

doi: 10.1002/cncr.31753.

New drug option for men with aggressive prostate cancer

PMID: 30412304
DOI: 10.1002/cncr.31753

Free article

Comment

New drug option for men with aggressive prostate cancer

Carrie Printz. Cancer. 2018.

Free article

. 2018 Oct 1;124(19):3797.

doi: 10.1002/cncr.31753.

Author

PMID: 30412304
DOI: 10.1002/cncr.31753

No abstract available

PubMed Disclaimer

Comment on

Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer.
Hussain M, Fizazi K, Saad F, Rathenborg P, Shore N, Ferreira U, Ivashchenko P, Demirhan E, Modelska K, Phung D, Krivoshik A, Sternberg CN. Hussain M, et al. N Engl J Med. 2018 Jun 28;378(26):2465-2474. doi: 10.1056/NEJMoa1800536. N Engl J Med. 2018. PMID: 29949494 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information